BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11260542)

  • 1. Mohs micrographic surgery for the treatment of spindle cell tumors of the skin.
    Huether MJ; Zitelli JA; Brodland DG
    J Am Acad Dermatol; 2001 Apr; 44(4):656-9. PubMed ID: 11260542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermatofibrosarcoma protuberans: a report on 29 patients treated by Mohs micrographic surgery with long-term follow-up and review of the literature.
    Snow SN; Gordon EM; Larson PO; Bagheri MM; Bentz ML; Sable DB
    Cancer; 2004 Jul; 101(1):28-38. PubMed ID: 15221986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dermatofibrosarcoma protuberans: wide local excision vs. Mohs micrographic surgery.
    Paradisi A; Abeni D; Rusciani A; Cigna E; Wolter M; Scuderi N; Rusciani L; Kaufmann R; Podda M
    Cancer Treat Rev; 2008 Dec; 34(8):728-36. PubMed ID: 18684568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mohs micrographic surgery in the treatment of rare aggressive cutaneous tumors: the Geisinger experience.
    Thomas CJ; Wood GC; Marks VJ
    Dermatol Surg; 2007 Mar; 33(3):333-9. PubMed ID: 17338692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mohs micrographic surgery and dermatofibrosarcoma protuberans: a multidisciplinary approach in 44 patients.
    Nelson RA; Arlette JP
    Ann Plast Surg; 2008 Jun; 60(6):667-72. PubMed ID: 18520205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extramammary Paget's disease: surgical treatment with Mohs micrographic surgery.
    Hendi A; Brodland DG; Zitelli JA
    J Am Acad Dermatol; 2004 Nov; 51(5):767-73. PubMed ID: 15523356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wide excision or Mohs micrographic surgery for the treatment of primary dermatofibrosarcoma protuberans.
    Meguerditchian AN; Wang J; Lema B; Kraybill WG; Zeitouni NC; Kane JM
    Am J Clin Oncol; 2010 Jun; 33(3):300-3. PubMed ID: 19858696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dermatofibrosarcoma protuberans treated with Mohs micrographic surgery: cure rates and surgical margins.
    Dawes KW; Hanke CW
    Dermatol Surg; 1996 Jun; 22(6):530-4. PubMed ID: 8646467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes in 11 patients with dermatofibrosarcoma protuberans treated with Mohs micrographic surgery.
    Galimberti G; MontaƱo AP; Kowalczuk A; Ferrario D; Galimberti R
    Int J Dermatol; 2012 Jan; 51(1):89-93. PubMed ID: 22182384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More than 2 decades of treating atypical fibroxanthoma at mayo clinic: what have we learned from 91 patients?
    Ang GC; Roenigk RK; Otley CC; Kim Phillips P; Weaver AL
    Dermatol Surg; 2009 May; 35(5):765-72. PubMed ID: 19389106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution.
    DuBay D; Cimmino V; Lowe L; Johnson TM; Sondak VK
    Cancer; 2004 Mar; 100(5):1008-16. PubMed ID: 14983497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myofibrosarcoma treated with Mohs micrographic surgery.
    Chiller K; Parker D; Washington C
    Dermatol Surg; 2004 Dec; 30(12 Pt 2):1565-7. PubMed ID: 15606842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localized cutaneous metastases from an atypical fibroxanthoma.
    Giuffrida TJ; Kligora CJ; Goldstein GD
    Dermatol Surg; 2004 Dec; 30(12 Pt 2):1561-4. PubMed ID: 15606841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of dermatofibroma sarcoma protuberans using modified Mohs micrographic surgery: no recurrences and smaller defects.
    Hancox JG; Kelley B; Greenway HT
    Dermatol Surg; 2008 Jun; 34(6):780-4. PubMed ID: 18318720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spindle cell neoplasms encountered in dermatologic surgery: a review.
    Hollmig ST; Sachdev R; Cockerell CJ; Posten W; Chiang M; Kim J
    Dermatol Surg; 2012 Jun; 38(6):825-50. PubMed ID: 22268379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermatofibrosarcoma protuberans (DFSP): growth characteristics based on tumor modeling and a review of cases treated with Mohs micrographic surgery.
    Haycox CL; Odland PB; Olbricht SM; Casey B
    Ann Plast Surg; 1997 Mar; 38(3):246-51. PubMed ID: 9088462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up.
    Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
    J Am Acad Dermatol; 2005 Sep; 53(3):452-7. PubMed ID: 16112352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scalp tumors treated with Mohs micrographic surgery: clinical features and surgical outcome.
    Leibovitch I; Huilgol SC; Richards S; Paver R; Selva D
    Dermatol Surg; 2006 Nov; 32(11):1369-74. PubMed ID: 17083590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staged excision versus Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma.
    Walling HW; Scupham RK; Bean AK; Ceilley RI
    J Am Acad Dermatol; 2007 Oct; 57(4):659-64. PubMed ID: 17870430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermatofibrosarcoma protuberans: 35 patients treated with Mohs micrographic surgery using paraffin sections.
    Tan WP; Barlow RJ; Robson A; Kurwa HA; McKenna J; Mallipeddi R
    Br J Dermatol; 2011 Feb; 164(2):363-6. PubMed ID: 20973768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.